Regeneron Pharmaceuticals Inc (REGN)
Pretax margin
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 5,145,100 | 4,874,800 | 4,984,200 | 4,779,900 | 4,969,400 | 4,587,200 | 4,042,000 | 4,199,300 | 4,376,400 | 4,775,400 | 4,655,700 | 4,858,800 | 6,037,500 | 6,344,300 | 9,133,900 | 9,325,800 | 8,047,000 | 7,228,700 | 4,394,800 | 3,810,400 |
| Revenue (ttm) | US$ in thousands | 14,247,800 | 14,214,200 | 14,085,700 | 14,202,000 | 13,847,100 | 13,489,100 | 13,100,100 | 13,117,200 | 13,097,300 | 12,670,800 | 12,369,900 | 12,172,900 | 13,710,200 | 14,226,800 | 16,508,100 | 16,071,700 | 13,542,900 | 12,384,100 | 9,197,600 | 8,497,100 |
| Pretax margin | 36.11% | 34.30% | 35.38% | 33.66% | 35.89% | 34.01% | 30.85% | 32.01% | 33.41% | 37.69% | 37.64% | 39.91% | 44.04% | 44.59% | 55.33% | 58.03% | 59.42% | 58.37% | 47.78% | 44.84% |
September 30, 2025 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $5,145,100K ÷ $14,247,800K
= 36.11%
Peer comparison
Sep 30, 2025
Company name
Symbol
Pretax margin
Regeneron Pharmaceuticals Inc
REGN
36.11%
Arrowhead Pharmaceuticals Inc
ARWR
6.62%
Biomarin Pharmaceutical Inc
BMRN
21.95%